Lonza | LONN - Operating Expenses

Stock Price
512.20
Daily Change
-1.80 -0.35%
Monthly
-1.16%
Yearly
-4.62%
Q2 Forecast
499.29

Lonza reported CHF2.9B in Operating Expenses for its fiscal semester ending in June of 2025.





Operating Expenses Change Date
Akzo Nobel EUR 2.16B 95M Dec/2025
Alcon AG USD 2.41B 123M Dec/2025
Almirall EUR 517.4M 32K Dec/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
BASF EUR 14.21B 372M Dec/2025
Bayer EUR 10.33B 126M Dec/2025
Beiersdorf EUR 4.16B 212M Dec/2025
Covestro EUR 3.24B 5.46B Dec/2025
Demant DKK 9.63B 241M Dec/2025
Fresenius EUR 5.25B 337M Dec/2025
Fresenius Medical Care EUR 4.41B 27.91M Dec/2025
Geberit CHF 581.3M 1.3M Dec/2025
Genmab DKK 798M 235M Dec/2025
Givaudan CHF 3B 107M Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GN Store Nord DKK 4.11B 490M Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Johnson Matthey GBP 5.21B 600M Dec/2025
Merck EUR 4.78B 669M Dec/2025
Novartis USD 9.8B 61M Dec/2025
Philips EUR 4.38B 405M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
Sika AG CHF 4.8B 78.3M Dec/2025
Smith & Nephew USD 2.52B 84M Dec/2025
Solvay EUR 1.03B 24M Dec/2025
UCB EUR 2.96B 196M Dec/2025